Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 3.215
-0.005 (-0.16%)
At close: Dec 30, 2025
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 407.71 million as of December 31, 2025. Its market cap has increased by 32.57% in one year.
Market Cap
407.71M
Enterprise Value
336.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.22
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 407.71M, a decrease of -27.50%. That is a compound annual growth rate of -4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 407.71M | 45.28% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.70B |
| Getinge AB | 59.59B |
| Sectra AB | 48.36B |
| Camurus AB | 36.74B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.33B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.68B |